The article discusses four dividend stocks priced under $50, each with a yield exceeding 4%. These companies are recognized for their ability to sustain and increase dividends, which is crucial for passive income investors. Among them is Pfizer Inc., known for its COVID vaccine yet valued for its consistent dividend growth and an impressive oncology pipeline. Despite recent revenue declines, Pfizer aims for significant cost savings and has a robust cash flow that supports its dividend strategy, making it a compelling option for investors.
"Dividend stocks can set you up for life. But, making the right choice will determine whether you enjoy a steady income or receive the same dividend amount year after year."
Collection
[
|
...
]